Orris

Approach to infection and non infection pneumonia full details for diagnosis of case

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have extensive source material. Let me compile the comprehensive answer.

Approach to Infectious and Non-Infectious Pneumonia: Full Diagnostic Framework

1. DEFINITION

Pneumonia is an acute infection or inflammation of the lung parenchyma (alveoli and/or interstitium), manifesting as fever, cough, sputum, dyspnea, and a new pulmonary infiltrate on imaging. A critical first step in every case is determining whether the cause is infectious or non-infectious, since this determines management entirely.
  • Goldman-Cecil Medicine, p. 992

2. CLASSIFICATION BY ACQUISITION SETTING

CategoryDefinition
Community-Acquired Pneumonia (CAP)Onset outside hospital or within 48h of admission
Hospital-Acquired Pneumonia (HAP)Onset >48h after hospital admission
Ventilator-Associated Pneumonia (VAP)HAP in mechanically ventilated patients
Aspiration PneumoniaInhalation of oropharyngeal/gastric contents
Pneumonia in Immunocompromised HostHIV, transplant, chemotherapy, steroids

3. CLINICAL MANIFESTATIONS

Classic presentation (bacterial/viral)

  • Cough - productive (purulent, blood-tinged) or non-productive
  • Fever, chills, sweats
  • Tachypnea, dyspnea
  • Pleuritic chest pain
  • GI symptoms (nausea, vomiting, diarrhea) in up to 20%
  • Fatigue, myalgias, headache

Atypical / "walking" pneumonia (Mycoplasma, Chlamydia, viral)

  • Insidious onset; patient may not appear very ill
  • Dry (non-productive) cough predominates
  • Constitutional symptoms prominent

Elderly patients - atypical presentation

  • The classic triad (fever + dyspnea + productive cough) is absent in >40% of older adults
  • Instead: malaise, confusion, falls, urinary incontinence, decline in functional status
  • Any neurologic symptoms should raise concern for concurrent meningitis
  • Harrison's Principles of Internal Medicine, p. 1068; Goldman-Cecil Medicine, p. 994

4. PHYSICAL EXAMINATION FINDINGS

FindingSignificance
Crackles (crepitations) over affected lobeBacterial consolidation
Bronchial breath soundsLobar consolidation
Egophony ("A" sounds like "E")Consolidation strongly suggested
Dullness to percussionConsolidation or pleural effusion
Increased tactile fremitusInfiltrate (reduced over effusion)
Tachypnea >25/minRespiratory compromise
SpO2 <92%Significant hypoxemia
HypotensionSepsis - poor prognosis
Note: Sensitivity 58%, specificity 67% - physical exam cannot replace imaging.
  • Goldman-Cecil Medicine, p. 994; Harrison's, p. 1068

5. DIAGNOSTIC APPROACH - STEP BY STEP

Step 1: Clinical Diagnosis

The diagnosis of pneumonia requires compatible clinical manifestations PLUS new opacities on chest imaging.
Ask two key questions:
  1. Is this pneumonia?
  2. What is the likely pathogen (or is it non-infectious)?

Step 2: Chest Imaging

Chest X-ray (first-line)

Essential for confirming pneumonia. Patterns and associated organisms:
Radiographic PatternMost Common Organisms
Lobar consolidationS. pneumoniae, K. pneumoniae
Bronchopneumonia (patchy, bilateral)S. aureus, gram-negative bacilli, anaerobes, S. pneumoniae
Round pneumoniaS. pneumoniae
Interstitial/reticulonodularViruses, Mycoplasma pneumoniae
CavitationM. tuberculosis, S. aureus, gram-negative rods, anaerobes
Upper-lobe cavitationM. tuberculosis (classic)
PneumatocelesS. aureus
Important caveat: radiographic patterns cannot reliably differentiate pathogens - overlap is common. Imaging determines extent and detects complications (cavitation, abscess, pneumothorax, pleural effusion), not etiology.
  • Grainger & Allison's Diagnostic Radiology, p. 3151-3157

Chest CT (when indicated)

  • Higher sensitivity than CXR; detects abnormalities up to 5 days earlier
  • Indicated when:
    • Clinical suspicion + normal/non-specific CXR
    • Immunocompromised patient (neutropenia)
    • Persistent or recurrent infiltrates
    • Need to distinguish pneumonia from COPD exacerbation, heart failure, PE, malignancy
  • HRCT (thin slices <2 mm) is preferred for interstitial patterns

Lung Ultrasound

  • Attractive point-of-care option but standardized criteria lacking; does not replace CXR

Step 3: Laboratory Investigations

Routine labs (all hospitalized patients)

  • CBC with differential: leukocytosis (bacterial), leukopenia (viral/severe), eosinophilia (eosinophilic pneumonia, fungal)
  • BMP/metabolic panel: blood urea nitrogen (used in severity scoring), electrolytes, renal/liver function
  • CRP, ESR: non-specific markers of inflammation
  • Procalcitonin: elevated in bacterial infection; however, guidelines recommend against using procalcitonin alone to decide on antibiotics in CAP

Microbiologic workup

TestWhen to Use
Sputum Gram stain + cultureAll hospitalized patients; ideally before antibiotics
Blood cultures x2Hospitalized patients, especially severe CAP (yield ~5-14%)
Urinary antigen - PneumococcalModerate-severe CAP
Urinary antigen - LegionellaSuspected Legionella (epidemic, travel, hotel/cruise exposure)
Nasopharyngeal swab PCR (influenza, SARS-CoV-2, RSV)Rapid point-of-care; guides antiviral vs. antibacterial choice
Multiplex respiratory PCR panelComprehensive viral/atypical pathogen detection
Serology (Mycoplasma, Chlamydia, Legionella)Atypical pneumonia, epidemic setting
BAL (bronchoalveolar lavage)Immunocompromised, non-resolving pneumonia, suspected PJP
Thoracentesis + pleural fluid analysisParapneumonic effusion (occurs in up to 60% of CAP)
HIV testAll adults <45 years or risk factors present
Fungal cultures/serologyEndemic area, immunocompromised, appropriate exposure history
  • Goldman-Cecil Medicine, p. 994-996; Harrison's, p. 1068-1071

6. COMMON INFECTIOUS PATHOGENS BY CLINICAL CONTEXT

Patient GroupMost Likely Pathogens
Outpatient, no comorbiditiesS. pneumoniae, M. pneumoniae, C. pneumoniae, H. influenzae, respiratory viruses
Outpatient + comorbiditiesAbove + DRSP, enteric gram-negatives, anaerobes
Inpatient, non-ICUS. pneumoniae, H. influenzae, Mycoplasma, C. pneumoniae, enteric gram-negatives, viruses, Legionella
Severe CAP (ICU), no Pseudomonas riskS. pneumoniae (including DRSP), Legionella, H. influenzae, gram-negative rods, S. aureus, M. pneumoniae
Severe CAP + Pseudomonas riskAll above + P. aeruginosa
AspirationAnaerobes, S. aureus, gram-negative rods (Candida rare)
HIV/ImmunocompromisedPneumocystis jirovecii (PCP), Cryptococcus, endemic fungi, CMV, M. tuberculosis
Bronchiectasis / Cystic fibrosisP. aeruginosa, Burkholderia cepacia, S. aureus, Aspergillus, NTM
Cavitary diseaseM. tuberculosis, S. aureus, gram-negative rods, anaerobes, endemic fungi
  • Fishman's Pulmonary Diseases, p. 2990-3022

7. EPIDEMIOLOGIC CLUES FOR UNUSUAL PATHOGENS

Exposure / ConditionSuspect Pathogen
Southwest USACoccidioides immitis
Midwest / Mississippi River basin, bat exposureHistoplasma capsulatum
Exposure to parrots/parakeetsChlamydia psittaci (psittacosis)
Exposure to pigeonsCryptococcus neoformans
Exposure to rabbitsFrancisella tularensis (tularemia)
Farm animalsCoxiella burnetii (Q fever)
Hotel/cruise shipLegionella pneumophila
Incarceration, homelessness, endemic travelM. tuberculosis
Pandemic conditionsSARS-CoV-2
IV drug useS. aureus, septic emboli
  • Goldman-Cecil Medicine, Table 85-2

8. DIFFERENTIAL DIAGNOSIS - NON-INFECTIOUS CAUSES

About 15-20% of patients hospitalized for "pneumonia" have a non-infectious etiology.

A. Non-Infectious Mimics (Acute/Subacute)

ConditionKey Features
Acute heart failure / pulmonary edemaMost common non-infectious mimic; elevated BNP, bilateral infiltrates, orthopnea
Pulmonary embolism with infarctionPleuritic pain, pleural infiltrate, risk factors (DVT, immobility), D-dimer elevated
ARDSBilateral infiltrates, hypoxemia, preceding trigger (sepsis, aspiration, trauma)
Pulmonary hemorrhageHemoptysis, falling hemoglobin, diffuse infiltrates
Acute eosinophilic pneumoniaYoung adults, acute febrile illness, eosinophilia on BAL (>25% eos)
Drug-induced pneumonitisTemporal link to drug (amiodarone, methotrexate, nitrofurantoin, chemotherapy)
Radiation pneumonitisHistory of thoracic radiation, within field of radiation
Aspiration pneumonitisChemical injury from acid aspiration (Mendelson's); differs from aspiration pneumonia
Lung cancerPostobstructive pneumonia; persistent or recurrent infiltrate in same location

B. Non-Infectious Interstitial Lung Diseases (Chronic/Subacute)

These frequently get initially misdiagnosed as CAP:
ConditionKey Features
Cryptogenic Organizing Pneumonia (COP)Migratory/fleeting infiltrates, responds to corticosteroids, BAL shows mixed pattern
Chronic Eosinophilic Pneumonia (CEP)Peripheral consolidation ("photographic negative" of pulmonary edema), peripheral eosinophilia
Hypersensitivity Pneumonitis (HP)Antigen exposure history (birds, mold, farmer's lung); micronodules on CT, upper-mid zone
SarcoidosisBilateral hilar adenopathy, elevated ACE, multisystem involvement
Idiopathic Pulmonary Fibrosis (IPF)Bibasilar reticular/honeycombing on HRCT, decreased DLCO, older males
Nonspecific Interstitial Pneumonia (NSIP)Lower lobe predominant, often in connective tissue disease
Acute Interstitial Pneumonia (AIP)Rapid progression, diffuse bilateral infiltrates, poor prognosis
Vasculitis (GPA, EGPA)Hemoptysis, systemic vasculitis features, ANCA positive
Connective tissue disease-ILDRA, SLE, SSc; extra-pulmonary autoimmune features
CT pattern guidance for non-infectious ILD:
CT PatternConsider
Honeycombing (lower lobe)IPF, fibrotic NSIP, asbestosis
Migratory/fleeting infiltratesCOP, HP, eosinophilic granulomatosis, Loeffler syndrome
Peripheral consolidationCEP, COP
Upper/mid-zone predominanceHP, sarcoidosis, Langerhans cell histiocytosis
MicronodulesInfection, HP, sarcoidosis
Bilateral hilar adenopathySarcoidosis, lymphoma, infection
  • Goldman-Cecil Medicine, block 11, p. 101-137 (ILD classification); p. 995-996 (differential)

9. SEVERITY ASSESSMENT

PSI (Pneumonia Severity Index / PORT Score)

  • Uses 20 variables (demographics, comorbidities, physical signs, labs, imaging)
  • Classes I-III: low risk, outpatient treatment appropriate (score ≤90)
  • Classes IV-V (score >90): higher risk, hospitalization indicated
  • Score >130 or Class V: ICU/intermediate care warranted

CURB-65 Score (simpler, emergency use)

FactorPoints
Confusion1
Urea >7 mmol/L (BUN >19 mg/dL)1
Respiratory rate ≥30/min1
Blood pressure systolic <90 or diastolic ≤601
Age ≥ 651
  • Score 0-1: outpatient
  • Score 2: consider admission
  • Score ≥3: hospitalize; score ≥4 consider ICU

Criteria for Severe CAP (ATS/IDSA)

  • Respiratory rate >30/min, PaO2/FiO2 <250
  • Multilobar infiltrates, confusion/disorientation
  • BUN >20 mg/dL, WBC <4000
  • Platelet <100,000, temperature <36°C
  • Hypotension requiring aggressive fluids
  • Goldman-Cecil Medicine, p. 995; Harrison's, p. 1070

10. DIAGNOSTIC ALGORITHM SUMMARY

Suspected Pneumonia
        |
        ├── History + Physical Exam
        |       - Fever, cough, dyspnea, sputum, pleuritic pain
        |       - Crackles, bronchial breathing, dullness
        |       - Epidemiologic clues
        |
        ├── CHEST X-RAY (mandatory)
        |       - New infiltrate confirms pneumonia
        |       - Pattern guides differential
        |       - No infiltrate = bronchitis, COPD exacerbation, asthma
        |
        ├── BLOODS: CBC, CRP, BMP, LFTs, blood cultures
        |
        ├── MICROBIOLOGIC WORKUP
        |       - Sputum Gram stain/culture
        |       - Urinary antigens (pneumococcal, Legionella)
        |       - Nasopharyngeal PCR (influenza, SARS-CoV-2)
        |       - Serology if atypical pattern
        |
        ├── SEVERITY ASSESSMENT: PSI or CURB-65
        |       → Outpatient / Inpatient / ICU decision
        |
        ├── CONSIDER NON-INFECTIOUS CAUSES (15-20% of admissions)
        |       - BNP for heart failure
        |       - D-dimer/CT-PA for pulmonary embolism
        |       - Drug history for drug pneumonitis
        |       - Eosinophil count (peripheral + BAL) for eosinophilic pneumonia
        |       - ANA, ANCA, anti-GBM for autoimmune/vasculitic causes
        |       - HRCT if interstitial disease suspected
        |
        └── DIAGNOSIS + TREATMENT
                - Infectious: empiric antibiotics → targeted on cultures
                - Non-infectious: remove trigger, corticosteroids (COP, HP, eosinophilic)

11. KEY DISTINGUISHING FEATURES: INFECTIOUS vs. NON-INFECTIOUS

FeatureInfectious PneumoniaNon-Infectious Pneumonia
OnsetAcute (hours to days)Subacute/chronic (weeks to months)
FeverUsually high (>38.5°C)Low-grade or absent
SputumPurulent or mucopurulentScant or absent
WBCLeukocytosis (neutrophilia)Normal, eosinophilia (in eosinophilic), lymphocytosis
ProcalcitoninElevated in bacterialNormal/low
Blood culturesMay be positiveNegative
CXR patternLobar/segmental consolidationDiffuse, bilateral, interstitial, migratory
Response to antibioticsImprovement in 48-72hNo response
BALOrganisms on cultureEosinophils >25% (eosinophilic), lymphocytosis (HP), foamy macrophages (COP)
Drug/exposure historyLess relevantOften key clue
RecurrenceUnusual (same lobe)Common (COP, eosinophilic)

12. SPECIAL POPULATIONS

Immunocompromised

  • Add: P. jirovecii (PCP - classic in HIV, CD4 <200), CMV, Aspergillus, Cryptococcus, endemic fungi, NTM
  • LDH elevated in PCP; CT shows ground-glass opacity
  • BAL is the diagnostic procedure of choice

Elderly

  • Atypical presentation (confusion, falls) with absent fever and cough in >40%
  • Higher threshold for imaging
  • Higher mortality; early hospitalization often appropriate

Hospital-Acquired / VAP

  • Think gram-negatives: P. aeruginosa, Klebsiella, Acinetobacter, E. coli, Enterobacter
  • Also: S. aureus (MRSA in ICU)
  • Quantitative cultures of BAL or tracheal aspirate aid diagnosis

Sources

  • Goldman-Cecil Medicine, 26th ed. (2-Volume), Chapter 85: Community-Acquired Pneumonia
  • Harrison's Principles of Internal Medicine, 22nd ed. (2025), Chapter on CAP
  • Fishman's Pulmonary Diseases and Disorders, 2-Volume Set, Chapter 125
  • Grainger & Allison's Diagnostic Radiology, Chapter 5 (Differential Diagnosis of CAP)
  • Goldman-Cecil Medicine, Chapter 80: Interstitial Lung Disease (non-infectious ILD classification and CT patterns)
This is a shared conversation. Sign in to Orris to start your own chat.